Department of Neurology
Grand Rounds Lecture Series
In addition to the main Neurology Grand Rounds series, the Department of Neurology is proud to host a variety of specialized lecture and symposium events, including Global Health Neurology Grand Rounds, the Multicultural Alzheimer's Prevention Project Grand Rounds and the McCance Center Lecture Series.
Neurology Grand Rounds RecordingsThis timely and informative seminar series addresses major topics in neurology, including stroke, epilepsy, and the neurological complications of COVID-19. For details about Grand Rounds and Mass General Brigham Continuing Professional Development, please visit the Neurology Grand Rounds course page. Selected lecture recordings are shared here.
Thursday, January 19, 2022: Using Digital Data to Quantify Behavior and Function in ALS and Hasten Drug Development
Dr. James Berry, MD, MPH, the Winthrop Family Scholar in ALS Sciences, Averill Healey Endowed Chair in ALS, Associate Chief for Neurotherapeutics, and Chief of the Division of ALS and Motor Neuron Diseases at MGH, discusses using Digital Data to Quantify Behavior and Function in ALS and Hasten Drug Development.
Thursday, December 15, 2022: Neurology Grand Rounds with Dr. Bradley Hyman, MD, PhD
Dr. Bradley Hyman, MD, PhD, the John B. Penny Professor of Neurology, Co-Vice Chair for Research in Neurology,and Director of the Massachusetts Alzheimer Disease Research Center at Massachusetts General Hospital, discusses the molecular underpinnings correlating with clinical heterogeneity in Alzheimer's Disease.
Thursday, September 29, 2022: Quantifying Diversity and Inclusion in Clinical Research
Dr. Jonathan Jackson, PhD, Executive Director of the Community Access, Recruitment, and Engagement (CARE) Research Center at Massachusetts General Hospital, examines diversity in clinical research and proposes a novel framework for understanding and improving representation and generalizability in clinical research.
Thursday, September 8, 2022: Neurology Grand Rounds: Angelman Syndrome and 15q Duplication Syndrome
Dr. Ronald Thibert, Director of the MGH Dup15 Clinic and the Angelman Syndrome Clinic and Co-Director of the Pitt Hopkins Syndrome Clinic discusses the growing role of rare disease clinics and gene therapy development to improve care and outcomes in patients with Angelman Syndrome and 15q Duplication Syndrome.
June 9, 2022: ALS in 2022: New Insights in Biology and Treatments
In the Richard Tyler Memorial Lecture, Mass General Chief of Neurology Merit Cudkowicz, MD, MSc discusses current treatment and diagnostic approaches in ALS, new clinicaltrial designs such as the HEALEY ALS Platform Trial and new treatment approaches being developed for people with ALS.
April 28, 2022: Women & Stroke: The Importance of Age and Sex
For the 2022 C. Miller Fisher Memorial Lecture, Louise D. McCullough, MD, PhD, the Chief of Neurology at Memorial Hermann Hospital, discusses sex differences in stroke and how they increase mortality and morbidity.
March 17, 2022: Innovating Care Models in Neuro-Oncology
Rochester University Neurologist and Oncologist Nimish Mohile, MD, MS, FAAN discusses the challenges of cancer care delivery for patients with primary brain tumors, ways to use design thinking approaches in modernizing clinical care and strategies to support innovation in academic neurology.
March 10, 2022: Neuro Aesthetics
Brigham & Women’s Neurologist Shahram Khoshbin, MD discusses the neurological basis of visual arts appreciation, ways in which physicians can enhance their clinical observational skills through visual arts principles, and the relationship between the arts and certain neurological disorders.
January 27, 2022: Infection as a Trigger for Arterial Ischemic Stroke: Lessons from Childhood Stroke Research
UCSF Professor Heather Fullerton, MD discusses mechanisms by which infection can contribute to the pathogenesis of arterial ischemic stroke. Dr. Fullerton is the Founder and President of the International Pediatric Stroke Organization (IPSO), a nonprofit organization that aims to improve the prevention, care and lifelong outcomes of children with cerebrovascular disease worldwide.
December 9, 2021: Precision Medicine & Drug Discovery
David Goldstein, PhD, the CEO and Co-Founder of Actio Biosciences, provides an introduction to diagnostic sequencing, its role in clinical practices, and assessment of its impact on drug development.
November 18, 2021: Autism for the Neurologist
University of Texas at Austin Neurologist Audrey Brumback, MD, PhD discusses subtle presentations of the core symptoms of autism, masking and camouflaging behaviors, and brain circuits being studied for their potential involvement in the condition.
October 21, 2021: Clinicopathological Conference: A 65-year-old Woman with a History of Childhood Measles Encephalitis
Christopher Stephen, MB ChB reviews the case of a 65-year-old woman with a history of childhood measles encephalitis now presenting with rapidly progressive right arm weakness and falls. He is joined by panelists Case Western Reserve Professor Brian Appelby, MD, Mass General Resident Marina Avetisyan, MD, PhD, Mass General Radiologist Pamela Shaefer, MD, and Mass General Neuropathologist Derek Oakley, MD, PhD.
September 2, 2021: Optogenetic and therapeutic approaches to slowing Alzheimer’s disease
Ksenia Kastanenka, PhD discusses the role of sleep rhythms in Alzheimer’s disease progression, how these rhythms can be manipulated in mouse models of the disease and the way that the new drug Aducanumab affects calcium levels in neurons.
July 22, 2021: Balancing Risk and Benefit: Protecting the Brain from Seizures and Overtreatment during Critical Illness
Sahar Zafar, MD discusses ways that physicians can protect the brain from seizures and the danger of overtreatment during care for critical illness. Dr. Zafar is the Associate Medical Director of the MGH Neuroscience Intensive Care Unit and Director of the Mass General Brigham Neurocritical Care Fellowship at Harvard Medical School.
July 15, 2021: Challenges in Medical Education
Tracey Cho, MD leads a discussion on the best ways to develop and share knowledge in clerkship and residency programs. Dr. Cho is the Vice Chair for Education at the University of Iowa Carver College of Medicine and a graduate of the Mass General Brigham Neurology Residency.
July 8, 2021: Clinicopathological Conference: A 67-year-old Man with Progressive Motor Neuron Disease
Meridale Baggett, MD reviews the case of a 67-year-old man with progressive motor neuron disease, obstructive sleep apnea, somnolence, and odd behaviors during sleep. She is joined by Mass General Neurologists Suma Babu, MD, MPH, MBBS; Jenny Linnoila, MD, PhD; Haatem Reda, MD and Aleksandar Videnovic, MD, MSc, as well as Neuroradiology Fellow Brian Zhao, MD.
May 20, 2021: C. Miller Fisher Visiting Professor Lecture: Out of Africa: Emerging Stroke Situation, Science, Scientists, and Strategies
Bruce Ovbiagele, MD, MSc, MAS, MBA presents information on the public promise and challenge of delivering and expanding stroke care throughout Africa. Dr. Ovbiagele is a professor of Neurology and an Associate Dean at the University of California, San Francisco.
May 13, 2021: Seizures after Acute Brain Injury
Kevin Staley, MD, the Chief of the Section of Child Neurology at Mass General and principal investigator of the Pediatric Epilepsy Research Lab, discusses brain injury and seizures.
April 8, 2021: Clinicopathological Conference: A 55-year-old Man with Hearing Loss & Eye Redness
Meridale Baggett, MD reviews the case of a 55-year-old man with bilateral hearing loss & eye redness. She is joined by UCSD Professor of Otolaryngology & Neurological Surgery Jeffrey Harris, MD, PhD, FACS; Mass General Infectious Disease Physician Andrea Ciaranello, MD; and Mass General Residents Mia Bothwell, MD, PhD and Elisabeth Tabb, MD.
March 25, 2021: Tyler Memorial Neurology Grand Rounds: Immune Mechanisms in Neurologic Diseases
Howard Weiner, MD discusses how the innate and adaptive immune systems contribute to neurologic disease and how they can be used to treat it. Dr. Weiner is the Robert L. Kroc Professor of Neurology at Harvard Medical School, the Director and Founder of the Brigham MS Center and the Co-Director of the Ann Romney Center for Neurologic Diseases at Brigham and Women's Hospital.
March 18, 2021: Three Short Stories in Neuroimmunology
Michael Levy, MD, PhD, director of the Mass General Neuroimmunology Clinic & Research Lab, discusses neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody disease (MOGAD), their immunological differences and treatment options.
February 18, 2021: Modeling the Complexity of Migraine: Challenges and Future Directions
Mass General Neurologist Andrea Harriott, MD, PhD, discusses the utility of in-vitro models of migraine in the preclinical setting and of behavioral models of migraine with aura in the preclinical setting.
February 11, 2021: Computable Neurologic Phenotypes in Pediatric Critical Care
University of Washington Professor Mark Wainwright, MD, PhD, FAAN discusses pediatric neurocritical care, including neuromonitoring methods and the potential of electronic health records and streaming physiologic data to identify risks of neurologic injury in the ICU.
January 28, 2021: Changing the Paradigm for ALS Clinical Trials
Sabrina Paganoni, MD, PhD presents the Krivickas Memorial Grand Rounds Lecture, focusing on the success of new clinical trials for ALS in the past year, including the CENTAUR trial and the HEALEY ALS Platform Trial.
January 21, 2021: Clinicopathological Conference: A 64-year-old Woman with Headaches, Memory Loss, and Cognitive Impairment
Meridale Baggett, MD reviews the case of a 64-year-old woman with 6 weeks of headaches, memory loss, and cognitive impairment. She is joined by Brigham & Women’s Neurologist Shamik Bhattacharyya, MD, MS; Mass General Neuropathology Fellow Samantha Champion, MD; Mass General Neurologist Bart Chwalisz, MD and Mass General Neuroradiologist Ramon Gonzalez, MD, PhD.
December 10, 2020: The Role of Pandemics in the Evolution and Destruction of the Human Brain
Avindra Nath, MD, Chief of the Section of Infections of the Nervous System at NIH, covers neurological complications associated with recent and remote pandemics, the way that pandemics have shaped human evolution and brain development, and how pathogens incorporated in the human genome from remote pandemics can influence the pathophysiology of neurodegenerative diseases.
November 19, 2020: Neuro-Vascular Interactions in the Brain
Chenghua Gu, DVM, PhD, a Professor of Neurobiology at Harvard Medical School, explains molecular mechanisms underlying the blood-brain barrier and neurovascular coupling.
September 17, 2020: Case Record Review with Meridale Baggett, MD
Meridale Baggett, MD, leads a case discussion about a 65-year-old man with eye pain and decreased vision. Dr. Baggett is the Associate Editor, New England Journal of Medicine Case Records of the Massachusetts General Hospital.
May 14, 2020: Case Study: A 60-year-old woman with COVID-19 and altered mental status
Moderator: Meridale Baggett, MD, Associate Editor, New England Journal of Medicine Case Records of the Massachusetts General Hospital
Panel: Aneesh Singhal, MD, Bart Chwalisz, MD, Shibani Mukerji, MD, PhD and Ramon Gonzalez, MD
April 30, 2020: Neurology & COVID-19 Research Update
Presenters Jonathan Rosand, MD, Mark Albers, MD and Eric Klawiter, MD, MSc share new information about COVID-19 clinical trials and ongoing research.
April 23, 2020: COVID-19 & Neurology: A Panel Discussion
Presenters Bart Chwalisz, MD, M. Brandon Westover, MD, PhD, Paloma Gonzalez-Perez, MD, PhD and Shibani Mukerji, MD, PhD discuss the neurological impacts of COVID-19.
Mass General Brigham is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.About Neurology Grand Rounds About Neuroscience Grand Rounds
Responding to COVID-19
Mass General has activated its Hospital Incident Command System (HICS) in response to the ongoing Coronavirus (COVID-19) pandemic. Please find the latest news and information here.